These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21466710)

  • 1. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
    BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
    Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
    Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
    Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.
    Lin L; Lu L; Yuan C; Wang A; Zhu M; Fu X; Xing S
    Bioorg Med Chem Lett; 2021 Jun; 41():127981. PubMed ID: 33766767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
    Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
    Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
    Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
    Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
    Hu L; Luo H; Wang W; Li H; He T
    PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
    Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
    J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
    Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
    Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
    Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
    Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma.
    Dong Q; Ding X; Chang B; Wang H; Wang A
    J Oral Pathol Med; 2016 Feb; 45(2):111-8. PubMed ID: 26041460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
    Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
    Dai N; Lu AP; Shou CC; Li JY
    World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
    Miskad UA; Semba S; Kato H; Yokozaki H
    Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.